CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,500 shares at $23.72 ($35,580)
- 4 Open-market sale CEO sold 148,940 shares at an average $22.76 ($3,389,452)
- 4 Planned sale CHIEF LEGAL OFFICER sold 5,000 shares at $25.00 ($125,000)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,065 shares at $23.63 ($72,425)
- 4 Open-market sale Chief Medical Officer sold 2,554 shares at $21.81 ($55,703)
- 4 Open-market sale Chief Legal Officer sold 2,305 shares at $21.81 ($50,272)
- 4 Open-market sale Chief Financial Officer sold 2,180 shares at $21.81 ($47,546)
- 4 Open-market sale CEO sold 6,866 shares at $21.81 ($149,747)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 882 shares at $14.19 ($12,516)
Page 6 of 15 · 298 filings